Get in touch with the right contacts for all of our services.
Nemours Children’s Health System is pleased to announce that an agreement has been finalized for Nemours Biomedical Research to lease space at the DuPont Experimental Station. Nemours will lease space in Building 400 on the DuPont Experimental Station Campus, which is located adjacent to Nemours/Alfred I. duPont Hospital for Children and the Nemours Estate.
DuPont recently announced a $200 million commitment to the DuPont Experimental Station, which has enjoyed a long legacy of excellence in research. Nemours is excited to be a part of this strong community of scientific study.
Nemours will lease two floors in Building 400, which will provide space for the relocation of:
- Nemours Center for Childhood Cancer Research
- Nemours Center for Orthopedic Research and Development
- Nemours Center for Pediatric Lung Research
- Nemours Center for Neuroscience Research
- Nemours Regenerative Medicine Lab
- Nemours Biomedical Engineering Research Program
- Nemours Histotechnology Core Lab
- Nemours Center for Applied Clinical Genomics
- Nemours Biomedical Research will lease the 4th and 5th floors of Building 400 consisting of approximately 85,000 sq. ft. of laboratory and supporting office space.
- The Experimental Station has more than 50 buildings and 2.3 million square feet of building space. Building 400, which was constructed in 1983, contains a 250-seat auditorium, multiple conference rooms, and the support facilities required for state-of-the-art medical research.
- Approximately 68 Nemours scientists, clinical investigators, post doctorate fellows and support staff will move into this facility. In addition, approximately 30 students from the University of Delaware and other area universities will participate in research programs using these facilities.
- Nemours Biomedical Research receives extensive federal funding through numerous investigator grant awards and through multi-institutional research grants. Last year Nemours Biomedical Research was ranked 11th in the nation for National Institutes of Health (NIH) pediatric research funding.
"Nemours and DuPont have a long history of innovation in Delaware, and the Experimental Station – the site of so many of DuPont’s scientific breakthroughs – continues to be a source of economic strength for our state. The bottom line is Delaware’s economy remains in transition, and we must do everything we can to support innovation, and make sure Delaware is competing with other states for jobs and talent. This agreement is a step in the right direction that will allow Nemours to access expanded research space and collaborate with DuPont and other companies at the site."
— John Carney,
"This move only furthers our continuous dedication to investing in the children in and around the state of Delaware and our commitment to being supportive and collaborative neighbors to other Delaware organizations. The relocation to the DuPont Experimental Station will not only provide Nemours with expanded and enhanced research laboratory space, it offers countless opportunities to connect with other companies and institutions as this campus evolves as an open innovation hub for our region. I also want to thank Governors Jack Markell and John Carney, whose leadership and persistent involvement helped ensure the success of this new partnership."
— Roy Proujansky, MD,
Chief Executive, Nemours Delaware Valley Operations
"The DuPont Experimental Station has a rich culture of innovation, stimulated by the unique and diverse points of view of its residents and partners. We welcome Nemours Biomedical Research to our site and look forward to our future together in driving innovation forward."
— Douglas Muzyka,
DuPont Senior Vice President and Chief Science & Technology Officer